Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;15(3):1355-1363.
doi: 10.1007/s11682-020-00334-2. Epub 2020 Aug 3.

Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study

Kevin J Sullivan  1   2 , Anran Liu  3 , Chung-Chou H Chang  4 , Ann D Cohen  5 , Brian J Lopresti  6 , Davneet S Minhas  6 , Charles M Laymon  6 , William E Klunk  5 , Howard Aizenstein  5 , Neelesh K Nadkarni  4   7 , David Loewenstein  8 , M Ilyas Kamboh  9 , Mary Ganguli  5 , Beth E Snitz  7
Affiliations
Free PMC article

Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study

Kevin J Sullivan et al. Brain Imaging Behav. 2021 Jun.
Free PMC article

Abstract

A true understanding of the distribution and functional correlates of Alzheimer's disease pathology in dementia-free older adults requires a population-based perspective. Here we report initial findings from a sample of 102 cognitively unimpaired participants (average age 77.2 years, 54.9% women, 13.7% APOE*4 carriers) recruited for neuroimaging from a larger representative population-based cohort participating in an ongoing longitudinal study of aging, the Monongahela-Youghiogheny Healthy Aging Team (MYHAT). All participants scored < 1.0 on the Clinical Dementia Rating (CDR) Scale, with 8 participants (7.8%) scoring CDR = 0.5. Participants completed a positron emission tomography scan using the tracers [C-11]Pittsburgh Compound-B (PiB) and [F-18]AV-1451 to estimate amyloid and tau deposition. PiB positivity was defined on a regional basis using established standardized uptake value ratio cutoffs (SUVR; cerebellar gray matter reference), with 39 participants (38.2%) determined to be PiB(+). Health history, lifestyle, and cognitive abilities were assessed cross-sectionally at the nearest annual parent MYHAT study visit. A series of adjusted regression analyses modeled cognitive performance as a function of global PiB SUVR and [F-18]AV-1451 SUVR in Braak associated regions 1, 3/4, and 5/6. In comparison to PiB(-) participants (n = 63), PiB(+) participants were older, less educated, and were more likely to be APOE*4 carriers. Global PiB SUVR was significantly correlated with [F-18]AV-1451 SUVR in all Braak-associated regions (r = .38-0.53, p < .05). In independent models, higher Global PiB SUVR and Braak 1 [F-18]AV-1451 SUVR were associated with worse performance on a semantic interference verbal memory test. Our findings suggest that brain amyloid is common in a community-based setting, and is associated with tau deposition, but both pathologies show few associations with concurrent cognitive performance in a dementia-free sample.

Keywords: Alzheimer’s disease; Amyloid; Neuroimaging; Population neuroscience; Tau.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

GE Healthcare holds a license agreement with the University of Pittsburgh based on the PiB PET technology used in this manuscript. Dr. Klunk is a co-inventor of PiB and, as such, has a financial interest in this license agreement. GE Healthcare provided no grant support for this study and had no role in the design or interpretation of results or preparation of this manuscript. All other authors have no conflicts of interest with this work, had full access to all of the data in the study, and take responsibility for the integrity of the data and the accuracy of the data analysis.

Figures

Figure 1.
Figure 1.
[F-18]AV-1451 (Tau) SUVR by Braak Region and Aβ Status
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, & Maruff P (2017). Cognitive impairment and decline in cognitively normal older adults with high amyloid-beta: A meta-analysis. Alzheimers Dement (Amst), 6, 108–121. doi:10.1016/j.dadm.2016.09.002 - DOI - PMC - PubMed
    1. Baker SL, Maass A, & Jagust WJ (2017). Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data Brief, 15, 648–657. doi:10.1016/j.dib.2017.10.024 - DOI - PMC - PubMed
    1. Beer JC, Snitz BE, Chang CH, Loewenstein DA, & Ganguli M (2018). Does a cognitive stress test predict progression from mild cognitive impairment to dementia equally well in clinical versus population-based settings? Int Psychogeriatr, 30(10), 1435–1445. doi:10.1017/S1041610217002666 - DOI - PMC - PubMed
    1. Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, … Ances BM (2016). Tau and Abeta imaging, CSF measures, and cognition in Alzheimer’s disease. Sci Transl Med, 8(338), 338ra366. doi:10.1126/scitranslmed.aaf2362 - DOI - PMC - PubMed
    1. Cohen AD, Mowrey W, Weissfeld LA, Aizenstein HJ, McDade E, Mountz JM, … Klunk WE (2013). Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage, 71, 207–215. doi:10.1016/j.neuroimage.2013.01.015 - DOI - PMC - PubMed

Substances